Topical pain creams for RSD and compounding options

RSD—also called complex regional pain syndrome (CRPS)—is a chronic pain condition that may follow injury, surgery or illness, although no clear trigger is always found. Burning pain, marked sensitivity to touch, swelling, stiffness, and changes in skin colour or temperature can persist for years. Topical pain creams for RSD may ease a small area, but they do not treat the underlying nervous-system disturbance on their own.

A compounding pharmacy can make an individualised cream or gel when a commercial product does not provide the desired strength, base or format. A prescription may combine a local anaesthetic or another active ingredient with a carefully selected vehicle. Evidence varies by ingredient, and compounded combinations are not automatically better than approved products, so treatment should be matched to symptoms and reviewed regularly.

What a compounded cream can offer

Mass-marketed medicines have a fixed formulation, standard packaging and established dosing information. A compounded preparation is made for a particular prescription and may alter the concentration, remove an irritating excipient, or provide a combination not sold as a ready-made product. The pharmacist remains responsible for the quality of ingredients, preparation, labelling and storage.

Lidocaine is the most familiar option for burning or touch-sensitive skin because it temporarily reduces signalling in superficial nerves. Capsaicin and menthol may also be considered, although capsaicin can initially feel hot. Compounded ketamine or amitriptyline creams are sometimes proposed, but CRPS-specific evidence is limited and absorption can cause unexpected effects.

More product does not necessarily mean more relief. Skin thickness, application area, broken skin, heat and occlusive dressings can change absorption. A pharmacist can specify the amount, frequency and treatment area, and can explain whether a standard patch or over-the-counter preparation is more appropriate.

Matching treatment to common symptoms

For allodynia, a thin layer of a local anaesthetic may be more useful than a stronger general pain medicine. Deep aching is less likely to respond well to a surface treatment, while muscle spasm and sleep problems usually need a broader plan. Recording pain, sleep and daily activities before treatment helps show whether a cream makes a meaningful difference.

Follow the prescription rather than increasing the dose or covering the area with heat. Test a small area if directed, keep numbing products away from the eyes and mouth, and avoid combining separate lidocaine or similar products without professional advice. Report burning, blistering, swelling or marked dizziness promptly.

RSD can also reshape confidence, relationships and work. The connection between identity and chronic pain explains how persistent symptoms may alter self-perception, making a shared, goal-based plan especially valuable. A topical treatment is one tool, not a measure of how serious or resilient a person is.

Working with an Australian compounding pharmacy

Australian patients commonly begin with a GP consultation covered by Medicare and a script, sometimes arranged through a neurologist or pain specialist. Pharmacists in Melbourne, Sydney, Brisbane, Adelaide and Perth can assess the formula, prepare it, and arrange courier supply where lawful. Expect to discuss quantity, repeat prescriptions, storage and the total price in Australian dollars before the preparation begins.

The Therapeutic Goods Administration regulates medicine quality and advertising, while state pharmacy authorities oversee practice. A patient-specific compounded medicine may not hold a listing in the Australian Register of Therapeutic Goods because it is not mass-marketed. Patients should avoid ordering prescription-strength creams from overseas without checking TGA and Australian Customs requirements; an overseas prescription does not automatically authorise supply here.

Medicare usually rebates the consultation rather than the compounded cream, and PBS subsidy is uncommon for patient-specific preparations. Private health cover may also have exclusions. Independent learning resources can help patients understand terminology before the conversation, but the pharmacist should confirm the exact formulation, regulatory status and likely out-of-pocket cost.

Questions to ask about ingredients, access and cost

A clear medication plan prevents different numbing products from being combined accidentally and creates a useful record for future reviews.

About the formulation

• Which active ingredient has evidence for my specific RSD symptoms?
• What strength, amount and frequency does the prescription allow?
• Does the cream contain fragrance, preservatives, alcohol or other allergens?
• Which body areas should be treated, and for how long?
• What side effects should prompt me to stop or seek advice?

Before ordering, ask the pharmacist to explain why this preparation is preferable to a ready-made patch or product. Confirm that a small trial and a follow-up review have been included in the plan.

About supply and cost

• Is the pharmacy Australian and operating under appropriate compounding standards?
• Is the quoted price inclusive of the script, preparation, packaging and courier?
• Could any Medicare, PBS or private-insurance subsidy apply?
• Can repeats be supplied, and what are the storage and disposal instructions?
• What happens if the cream causes irritation or gives no benefit?

Keep the prescription, ingredient list and payment receipt. If symptoms change or the formula is no longer effective, return to the prescriber rather than increasing the amount independently. A scheduled review also makes it easier to stop a product that adds irritation without meaningful relief.

Build a safe, reviewed pain-care plan

Topicals can work best alongside physiotherapy, gentle graded movement, pacing, sleep support and psychological care for pain. A pain specialist may also consider medicines that influence nerve pathways or inflammation, while rehabilitation addresses function rather than pain alone. Because CRPS varies, the plan should be adjusted rather than treated as a fixed sequence.

Do not apply compounded medicines to open wounds, infected skin or a numb area unless instructed otherwise. Avoid heating pads over treatment sites, and ask about driving or machine use if the formula may cause sleepiness, dizziness or dissociation. Rapidly spreading redness, fever, severe blistering or new neurological symptoms warrant prompt medical assessment.

If you are considering topical pain creams for RSD, book a medication review with your GP or pain specialist, then take a written plan to a compounding chemist. Start only as directed, document the response and arrange follow-up. This monitored pathway gives you a clear basis for continuing, adjusting or discontinuing the preparation.